{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:44:24Z","timestamp":1792856664890,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 165921"],"award-info":[{"award-number":["FRN 165921"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2015-03633"],"award-info":[{"award-number":["RGPIN-2015-03633"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fonds de recherche du Qu\u00e9bec - Sant\u00e9"},{"name":"Famille Louise & Andr\u00e9 Charron"},{"DOI":"10.13039\/100009408","name":"Brain Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02024-5","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:47:13Z","timestamp":1777340833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A digital twin methodology using retrospective patient data for sample size reduction in Alzheimer\u2019s disease clinical trials"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-4664","authenticated-orcid":false,"given":"Daniel","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3382-9563","authenticated-orcid":false,"given":"Shirin","family":"Golchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8432-7021","authenticated-orcid":false,"given":"D. Louis","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"2","key":"2024_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14283\/jpad.2017.12","volume":"4","author":"J Cummings","year":"2017","unstructured":"Cummings J, Fox N. Defining disease modifying therapy for Alzheimer\u2019s disease. J Prev Alzheimers Dis Published online. 2017;4(2):109\u201315. https:\/\/doi.org\/10.14283\/jpad.2017.12.","journal-title":"J Prev Alzheimers Dis. Published online"},{"issue":"2","key":"2024_CR2","doi-asserted-by":"publisher","first-page":"e70098","DOI":"10.1002\/trc2.70098","volume":"11","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, Zhou Y, Lee G, et al. Alzheimer\u2019s disease drug development pipeline: 2025. Alzheimer\u2019s Dement Transl Res Clin Interv. 2025;11(2):e70098. https:\/\/doi.org\/10.1002\/trc2.70098.","journal-title":"Alzheimer's Dement Transl Res Clin Interv"},{"issue":"1","key":"2024_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13195-023-01177-x","volume":"15","author":"M Ritchie","year":"2023","unstructured":"Ritchie M, Gillen DL, Grill JD. Recruitment across two decades of NIH-funded Alzheimer\u2019s disease clinical trials. Alzheimers Res Ther. 2023;15(1):28. https:\/\/doi.org\/10.1186\/s13195-023-01177-x.","journal-title":"Alzheimers Res Ther"},{"issue":"22","key":"2024_CR4","doi-asserted-by":"publisher","first-page":"e2673","DOI":"10.1212\/WNL.0000000000012022","volume":"96","author":"RJ Jutten","year":"2021","unstructured":"Jutten RJ, Sikkes SAM, Van der Flier WM, et al. Finding treatment effects in Alzheimer trials in the face of disease progression heterogeneity. Neurology. 2021;96(22):e2673\u201384. https:\/\/doi.org\/10.1212\/WNL.0000000000012022.","journal-title":"Neurology"},{"key":"2024_CR5","doi-asserted-by":"publisher","unstructured":"Alzheimer\u2019s Association. 2025 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2025;21(4):e70235. https:\/\/doi.org\/10.1002\/alz.70235.","DOI":"10.1002\/alz.70235"},{"issue":"1","key":"2024_CR6","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference. Nat Commun. 2018;9(1):4273. https:\/\/doi.org\/10.1038\/s41467-018-05892-0.","journal-title":"Nat Commun"},{"issue":"S6","key":"2024_CR7","doi-asserted-by":"publisher","first-page":"e086975","DOI":"10.1002\/alz.086975","volume":"20","author":"D Andrews","year":"2024","unstructured":"Andrews D, Collins DL, the Alzheimer\u2019s Disease Neuroimaging Initiative. A digital twin technique using external observational data to reduce sample sizes in clinical trials on Alzheimer\u2019s disease. Alzheimers Dement. 2024;20(S6):e086975. https:\/\/doi.org\/10.1002\/alz.086975.","journal-title":"Alzheimers Dement."},{"issue":"10","key":"2024_CR8","doi-asserted-by":"publisher","first-page":"e061840","DOI":"10.1002\/alz.061840","volume":"18","author":"P Delmar","year":"2022","unstructured":"Delmar P, Huang Z, Neve A, et al. Using an external control to contextualize efficacy data from patients with prodromal and mild Alzheimer\u2019s disease treated with gantenerumab in SCarlet RoAD and Marguerite RoAD open-label extension studies. Alzheimers Dement. 2022;18(10):e061840. https:\/\/doi.org\/10.1002\/alz.061840.","journal-title":"Alzheimers Dement"},{"key":"2024_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2147\/CLEP.S242097","volume":"12","author":"K Thorlund","year":"2020","unstructured":"Thorlund K, Dron L, Park JJ, Mills EJ. Synthetic and external controls in clinical trials \u2013 a primer for researchers. Clin Epidemiol. 2020;12:457\u201367. https:\/\/doi.org\/10.2147\/CLEP.S242097.","journal-title":"Clin Epidemiol"},{"issue":"2","key":"2024_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/bimj.201800395","volume":"62","author":"A Kopp\u2010Schneider","year":"2020","unstructured":"Kopp\u2010Schneider A, Calderazzo S, Wiesenfarth M. Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control. Biom J Biom Z. 2020;62(2):361\u201374. https:\/\/doi.org\/10.1002\/bimj.201800395.","journal-title":"Biom J Biom Z"},{"key":"2024_CR11","doi-asserted-by":"publisher","first-page":"100446","DOI":"10.1016\/j.conctc.2019.100446","volume":"16","author":"L Dron","year":"2019","unstructured":"Dron L, Golchi S, Hsu G, Thorlund K. Minimizing control group allocation in randomized trials using dynamic borrowing of external control data \u2013 an application to second line therapy for non-small cell lung cancer. Contemp Clin Trials Commun. 2019;16:100446. https:\/\/doi.org\/10.1016\/j.conctc.2019.100446.","journal-title":"Contemp Clin Trials Commun"},{"key":"2024_CR12","doi-asserted-by":"publisher","unstructured":"Dubois B, Villain N, Schneider L, et al. Alzheimer Disease as a Clinical-Biological Construct\u2014An International Working Group Recommendation. JAMA Neurol. Published online November 1, 2024. https:\/\/doi.org\/10.1001\/jamaneurol.2024.3770.","DOI":"10.1001\/jamaneurol.2024.3770"},{"key":"2024_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13859","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement Published online. 2024. https:\/\/doi.org\/10.1002\/alz.13859.","journal-title":"Alzheimers Dement Published online"},{"issue":"4","key":"2024_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, et al. NIA\u2010AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2024_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20(6):484\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(21)00066-1.","journal-title":"Lancet Neurol"},{"issue":"28","key":"2024_CR16","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1002\/sim.6728","volume":"34","author":"JG Ibrahim","year":"2015","unstructured":"Ibrahim JG, Chen MH, Gwon Y, Chen F. The Power Prior: theory and applications. Stat Med. 2015;34(28):3724\u201349. https:\/\/doi.org\/10.1002\/sim.6728.","journal-title":"Stat Med"},{"issue":"5","key":"2024_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/pst.2376","volume":"23","author":"C Burman","year":"2024","unstructured":"Burman C, Hermansson E, Bock D, Franz\u00e9n S, Svensson D. Digital twins and Bayesian dynamic borrowing: two recent approaches for incorporating historical control data. Pharm Stat. 2024;23(5):611\u201329. https:\/\/doi.org\/10.1002\/pst.2376.","journal-title":"Pharm Stat"},{"issue":"3","key":"2024_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41573-023-00638-0","volume":"22","author":"SJ Ruberg","year":"2023","unstructured":"Ruberg SJ, Beckers F, Hemmings R, et al. Application of Bayesian approaches in drug development: starting a virtuous cycle. Nat Rev Drug Discov. 2023;22(3):235\u201350. https:\/\/doi.org\/10.1038\/s41573-023-00638-0.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2024_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12874-025-02647-6","volume":"25","author":"PE Poulet","year":"2025","unstructured":"Poulet PE, Tran M, Du Montcel ST, et al. Prediction-powered inference for clinical trials: application to linear covariate adjustment. BMC Med Res Methodol. 2025;25(1):204. https:\/\/doi.org\/10.1186\/s12874-025-02647-6.","journal-title":"BMC Med Res Methodol."},{"issue":"S9","key":"2024_CR20","doi-asserted-by":"publisher","first-page":"e054657","DOI":"10.1002\/alz.054657","volume":"17","author":"D Walsh","year":"2021","unstructured":"Walsh D, Schuler AM, Hall D, Walsh JR, Fisher CK. Using digital twins to reduce sample sizes while maintaining power and statistical accuracy. Alzheimers Dement. 2021;17(S9):e054657. https:\/\/doi.org\/10.1002\/alz.054657.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2024_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01073-0","volume":"7","author":"E Katsoulakis","year":"2024","unstructured":"Katsoulakis E, Wang Q, Wu H, et al. Digital twins for health: a scoping review. Npj Digit Med. 2024;7(1):77. https:\/\/doi.org\/10.1038\/s41746-024-01073-0.","journal-title":"Npj Digit Med"},{"key":"2024_CR22","doi-asserted-by":"publisher","first-page":"e55015","DOI":"10.2196\/55015","volume":"27","author":"V Riahi","year":"2025","unstructured":"Riahi V, Diouf I, Khanna S, Boyle J, Hassanzadeh H. Digital twins for clinical and operational decision-making: scoping review. J Med Internet Res. 2025;27:e55015. https:\/\/doi.org\/10.2196\/55015.","journal-title":"J Med Internet Res"},{"issue":"7","key":"2024_CR23","doi-asserted-by":"publisher","first-page":"e13897","DOI":"10.1111\/cts.13897","volume":"17","author":"AA Vidovszky","year":"2024","unstructured":"Vidovszky AA, Fisher CK, Loukianov AD, et al. Increasing acceptance of AI\u2010generated digital twins through clinical trial applications. Clin Transl Sci. 2024;17(7):e13897. https:\/\/doi.org\/10.1111\/cts.13897.","journal-title":"Clin Transl Sci"},{"issue":"6671","key":"2024_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1126\/science.adi6000","volume":"382","author":"AN Angelopoulos","year":"2023","unstructured":"Angelopoulos AN, Bates S, Fannjiang C, Jordan MI, Zrnic T. Prediction-powered inference. Science. 2023;382(6671):669\u201374. https:\/\/doi.org\/10.1126\/science.adi6000.","journal-title":"Science"},{"key":"2024_CR25","doi-asserted-by":"publisher","unstructured":"Vanderbeek AM, Vidovszky AA, Ross JL, et al. A Weighted Prognostic Covariate Adjustment Method for Efficient and Powerful Treatment Effect Inferences in Randomized Controlled Trials. arXiv. Preprint posted online September 25, 2023:arXiv:2309.14256. https:\/\/doi.org\/10.48550\/arXiv.2309.14256","DOI":"10.48550\/arXiv.2309.14256"},{"key":"2024_CR26","unstructured":"Unlearn and remynd Partner on Alzheimer\u2019s Study to Strengthen Confidence in Early Clinical Signals Using Digital Twins. Business Wire. 2025. https:\/\/www.businesswire.com\/news\/home\/20250403068288\/en\/Unlearn-and-remynd-Partner-on-Alzheimers-Study-to-Strengthen-Confidence-in-Early-Clinical-Signals-Using-Digital-Twins. Accessed 25 Jun 2025."},{"key":"2024_CR27","doi-asserted-by":"publisher","unstructured":"Angelopoulos AN, Duchi JC, Zrnic T. PPI++: Efficient Prediction-Powered Inference. arXiv. Preprint posted online March 26, 2024:arXiv:2311.01453. https:\/\/doi.org\/10.48550\/arXiv.2311.01453","DOI":"10.48550\/arXiv.2311.01453"},{"key":"2024_CR28","doi-asserted-by":"publisher","unstructured":"Shafiee N, Dadar M, Ducharme S, Collins DL. Automatic Prediction of Cognitive and Functional Decline Can Significantly Decrease the Number of Subjects Required for Clinical Trials in Early Alzheimer\u2019s Disease. J Alzheimer\u2019s Dis. 2021;84(3). https:\/\/doi.org\/10.3233\/JAD-210664","DOI":"10.3233\/JAD-210664"},{"key":"2024_CR29","doi-asserted-by":"publisher","unstructured":"Ross JL, Sabbaghi A, Zhuang R, et al. Enhancing Longitudinal Clinical Trial Efficiency with Digital Twins and Prognostic Covariate-Adjusted Mixed Models for Repeated Measures (PROCOVA-MMRM). arXiv. Preprint posted online April 26, 2024:arXiv:2404.17576. https:\/\/doi.org\/10.48550\/arXiv.2404.17576","DOI":"10.48550\/arXiv.2404.17576"},{"issue":"2","key":"2024_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1515\/ijb-2021-0072","volume":"18","author":"A Schuler","year":"2022","unstructured":"Schuler A, Walsh D, Hall D, Walsh J, Fisher C. Increasing the efficiency of randomized trial estimates via linear adjustment for a prognostic score. Int J Biostat. 2022;18(2):329\u201356. https:\/\/doi.org\/10.1515\/ijb-2021-0072.","journal-title":"Int J Biostat"},{"issue":"1","key":"2024_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-024-01540-6","volume":"16","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu S, Spiteri AG, et al. Understanding machine learning applications in dementia research and clinical practice: a review for biomedical scientists and clinicians. Alzheimers Res Ther. 2024;16(1):175. https:\/\/doi.org\/10.1186\/s13195-024-01540-6.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"2024_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3181cb3e25.","journal-title":"Neurology"},{"issue":"1","key":"2024_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2022","unstructured":"van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med Published online. 2022;388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med. Published online"},{"key":"2024_CR34","unstructured":"Eisai Inc., Biogen. A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer\u2019s Disease (Clarity AD): NCT03887455. ClinicalTrials.gov. 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03887455."},{"key":"2024_CR35","doi-asserted-by":"publisher","unstructured":"Andrews D, Arnold DL, Bzdok D, et al. Simulation-based power analysis could improve the design of clinical trials in Alzheimer\u2019s disease. medRXiv. Published online January 1, 2022:2022.12.24.22283807. https:\/\/doi.org\/10.1101\/2022.12.24.22283807.","DOI":"10.1101\/2022.12.24.22283807"},{"issue":"S21","key":"2024_CR36","doi-asserted-by":"publisher","first-page":"e074336","DOI":"10.1002\/alz.074336","volume":"19","author":"D Andrews","year":"2023","unstructured":"Andrews D, Arnold DL, Bzdok D, et al. Simulation-based effect size analysis in the absence of drug effects to inform the design of clinical trials in Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(S21):e074336. https:\/\/doi.org\/10.1002\/alz.074336.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"2024_CR37","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","volume":"65","author":"SE O\u2019Bryant","year":"2008","unstructured":"O\u2019Bryant SE. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer\u2019s Research Consortium study. Arch Neurol. 2008;65(8):1091. https:\/\/doi.org\/10.1001\/archneur.65.8.1091.","journal-title":"Arch Neurol"},{"issue":"1","key":"2024_CR38","doi-asserted-by":"publisher","first-page":"e14467","DOI":"10.1002\/alz.14467","volume":"21","author":"D Andrews","year":"2025","unstructured":"Andrews D, Ducharme S, Chertkow H, Sormani MP, Collins DL, Alzheimer\u2019s Disease Neuroimaging Initiative. The higher benefit of lecanemab in males compared to females in CLARITY AD is probably due to a real sex effect. Alzheimers Dement. 2025;21(1):e14467. https:\/\/doi.org\/10.1002\/alz.14467.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2024_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/ADR-230045","volume":"8","author":"MJ Garcia","year":"2024","unstructured":"Garcia MJ, Leadley R, Ross J, et al. Prognostic and Predictive Factors in Early Alzheimer\u2019s Disease: A Systematic Review. J Alzheimers Dis Rep. 2024;8(1):203\u201340. https:\/\/doi.org\/10.3233\/ADR-230045.","journal-title":"J Alzheimers Dis Rep"},{"issue":"4","key":"2024_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2307\/2528823","volume":"27","author":"JC Gower","year":"1971","unstructured":"Gower JC. A general coefficient of similarity and some of its properties. Biometrics. 1971;27(4):857\u201371. https:\/\/doi.org\/10.2307\/2528823.","journal-title":"Biometrics"},{"key":"2024_CR41","volume-title":"Causal Inference: What If","author":"MA Hern\u00e1n","year":"2020","unstructured":"Hern\u00e1n MA, Robins JM. Causal Inference: What If. Boca Raton: Chapman & Hall\/CRC; 2020."},{"key":"2024_CR42","unstructured":"Shaw LM, Trojanowski JQ. Biomarker Core report: Year1 ADNI3, Roche Elecsys immunoassay analyses of ADNI1\/GO\/2 CSF samples. Alzheimer\u2019s Association. https:\/\/www.alz.org\/getmedia\/6fe5fef7-69de-4940-9bf0-b8bdbe67f54c\/ww-adni-may-2017-biomarker-core-shaw.pdf."},{"issue":"7","key":"2024_CR43","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/brain\/awv112","volume":"138","author":"S Villeneuve","year":"2015","unstructured":"Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain. 2015;138(7):2020\u201333. https:\/\/doi.org\/10.1093\/brain\/awv112.","journal-title":"Brain"},{"issue":"10","key":"2024_CR44","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1038\/s41380-021-01263-2","volume":"26","author":"M Bucci","year":"2021","unstructured":"Bucci M, Chiotis K, Nordberg A, Alzheimer\u2019s Disease Neuroimaging Initiative. Alzheimer\u2019s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Mol Psychiatry. 2021;26(10):5888\u201398. https:\/\/doi.org\/10.1038\/s41380-021-01263-2.","journal-title":"Mol Psychiatry"},{"key":"2024_CR45","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 2021. https:\/\/www.R-project.org\/."},{"issue":"1","key":"2024_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1\u201348. https:\/\/doi.org\/10.18637\/jss.v067.i01.","journal-title":"J Stat Softw."},{"key":"2024_CR47","unstructured":"The Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). ADNI2 Procedures Manual. The Alzheimer\u2019s Disease Neuroimaging Initiative. 2011. https:\/\/adni.loni.usc.edu\/wp-content\/uploads\/2008\/07\/adni2-procedures-manual.pdf."},{"issue":"3-4","key":"2024_CR48","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000444216","volume":"41","author":"I Cova","year":"2016","unstructured":"Cova I, Clerici F, Maggiore L, et al. Body mass index predicts progression of mild cognitive impairment to dementia. Dement Geriatr Cogn Disord. 2016;41(3\u20134):172\u201380. https:\/\/doi.org\/10.1159\/000444216.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"10","key":"2024_CR49","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","volume":"47","author":"Y Stern","year":"2009","unstructured":"Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015\u201328. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2009.03.004.","journal-title":"Neuropsychologia"},{"issue":"2","key":"2024_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","volume":"4","author":"S Nakagawa","year":"2013","unstructured":"Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol. 2013;4(2):133\u201342. https:\/\/doi.org\/10.1111\/j.2041-210x.2012.00261.x.","journal-title":"Methods Ecol Evol"},{"key":"2024_CR51","doi-asserted-by":"publisher","first-page":"20170213","DOI":"10.1098\/rsif.2017.0213","volume":"14","author":"S Nakagawa","year":"2017","unstructured":"Nakagawa S, Johnson PCD, Schielzeth H. The coefficient of determination R2 and intra-class correlation coefficient from generalized linear mixed-effects models revisited and expanded. J R Soc Interface. 2017;14:20170213. https:\/\/doi.org\/10.1098\/rsif.2017.0213.","journal-title":"J R Soc Interface"},{"key":"2024_CR52","doi-asserted-by":"publisher","DOI":"10.4324\/9780203774441","volume-title":"Applied Multiple Regression\/Correlation Analysis for the Behavioral Sciences","author":"J Cohen","year":"2015","unstructured":"Cohen J, Aiken LS, Cohen P, West SG. Applied Multiple Regression\/Correlation Analysis for the Behavioral Sciences. Third edition. Routledge; 2015. https:\/\/doi.org\/10.4324\/9780203774441.","edition":"Third edition"},{"issue":"2","key":"2024_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00031305.1998.10480550","volume":"52","author":"A Agresti","year":"1998","unstructured":"Agresti A, Coull BA. Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions. Am Stat. 1998;52(2):119\u201326. https:\/\/doi.org\/10.1080\/00031305.1998.10480550.","journal-title":"Am Stat"},{"issue":"s1","key":"2024_CR54","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JAD-179901","volume":"64","author":"J Cummings","year":"2018","unstructured":"Cummings J, Ritter A, Zhong K. Clinical trials for disease-modifying therapies in alzheimer\u2019s disease: a primer, lessons learned, and a blueprint for the future. J Alzheimers Dis. 2018;64(s1):S3\u201322. https:\/\/doi.org\/10.3233\/JAD-179901.","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"2024_CR55","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12874-022-01799-z","volume":"22","author":"N Loiseau","year":"2022","unstructured":"Loiseau N, Trichelair P, He M, et al. External control arm analysis: an evaluation of propensity score approaches, G-computation, and doubly debiased machine learning. BMC Med Res Methodol. 2022;22(1):335. https:\/\/doi.org\/10.1186\/s12874-022-01799-z.","journal-title":"BMC Med Res Methodol"},{"issue":"18","key":"2024_CR56","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1212\/WNL.0000000000012777","volume":"97","author":"PC Austin","year":"2021","unstructured":"Austin PC, Yu AYX, Vyas MV, Kapral MK. Applying propensity score methods in clinical research in neurology. Neurology. 2021;97(18):856\u201363. https:\/\/doi.org\/10.1212\/WNL.0000000000012777.","journal-title":"Neurology"},{"issue":"6","key":"2024_CR57","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/awad024","volume":"146","author":"H Florian","year":"2023","unstructured":"Florian H, Wang D, Arnold SE, et al. Tilavonemab in early Alzheimer\u2019s disease: results from a phase 2, randomized, double-blind study. Brain. 2023;146(6):2275\u201384. https:\/\/doi.org\/10.1093\/brain\/awad024.","journal-title":"Brain"},{"issue":"4","key":"2024_CR58","doi-asserted-by":"publisher","first-page":"e70181","DOI":"10.1002\/trc2.70181","volume":"11","author":"D Wang","year":"2025","unstructured":"Wang D, Florian H, Lynch SY, et al. Using AI-generated digital twins to boost clinical trial efficiency in Alzheimer\u2019s disease. Alzheimers Dement Transl Res Clin Interv. 2025;11(4):e70181. https:\/\/doi.org\/10.1002\/trc2.70181.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"2024_CR59","unstructured":"Walsh J, UNLEARN AI. An updated digital twin generator for Alzheimer\u2019s disease (version 3.1). January 25, 2023. https:\/\/unlearnai.substack.com\/p\/an-updated-digital-twin-generator. Accessed 22 Sep 2023."},{"issue":"1","key":"2024_CR60","doi-asserted-by":"publisher","first-page":"e12226","DOI":"10.1002\/trc2.12226","volume":"7","author":"CJ Weber","year":"2021","unstructured":"Weber CJ, Carrillo MC, Jagust W, et al. The Worldwide Alzheimer\u2019s Disease Neuroimaging Initiative: ADNI\u20103 updates and global perspectives. Alzheimers Dement Transl Res Clin Interv. 2021;7(1):e12226. https:\/\/doi.org\/10.1002\/trc2.12226.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"issue":"7","key":"2024_CR61","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jalz.2015.05.005","volume":"11","author":"PS Aisen","year":"2015","unstructured":"Aisen PS, Petersen RC, Donohue M, Weiner MW, Alzheimer\u2019s Disease Neuroimaging Initiative. Alzheimer\u2019s Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans. Alzheimers Dement. 2015;11(7):734\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2015.05.005.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2024_CR62","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1017\/S1041610209009405","volume":"21","author":"KA Ellis","year":"2009","unstructured":"Ellis KA, Bush AI, Darby D, et al. The Australian imaging, biomarkers and lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer\u2019s disease. Int Psychogeriatr. 2009;21(4):672\u201387.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"2024_CR63","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","volume":"21","author":"DL Beekly","year":"2007","unstructured":"Beekly DL, Ramos EM, Lee WW, et al. The National Alzheimer\u2019s Coordinating Center (NACC) database: the uniform data set. Alzheimer Dis Assoc Disord. 2007;21(3):249\u201358. https:\/\/doi.org\/10.1097\/WAD.0b013e318142774e.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2024_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/alz.051903","author":"S Sivakumaran","year":"2021","unstructured":"Sivakumaran S, Hanan NJ, Cui Z, et al. The Critical Path for Alzheimer\u2019s Disease (CPAD) Consortium: A platform for pre\u2010competitive data sharing, standardization, and analysis to support quantitative tools for AD drug development. Alzheimers Dement. 2021. https:\/\/doi.org\/10.1002\/alz.051903.","journal-title":"Alzheimers Dement"},{"key":"2024_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fdata.2020.00024","volume":"3","author":"LL Raket","year":"2020","unstructured":"Raket LL. Statistical disease progression modeling in Alzheimer disease. Front Big Data. 2020;3:24. https:\/\/doi.org\/10.3389\/fdata.2020.00024.","journal-title":"Front Big Data"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02024-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02024-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02024-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:13:53Z","timestamp":1781140433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02024-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2024"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02024-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ADNI obtained ethics approval from all participating institutions, and all participants provided informed consent, in accordance with the Declaration of Helsinki. This study was conducted in accordance with the ADNI data use agreement and followed ethical guidelines for analysis of ADNI data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}